Log In
BCIQ
Print this Print this
 

Anti-Rabies mAb

  Manage Alerts
Collapse Summary General Information
Company Molecular Targeting Technologies Inc.
DescriptionHuman anti-rabies mAb
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationRabies
Indication DetailsPost-exposure treatment of rabies
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today